How Will InhaleRx’s Inhaled Drugs Transform Cancer Pain and Panic Disorder Treatment?

• FDA alignment achieved for IRX-211 Phase 2 trial design targeting breakthrough cancer pain
• Ethics approvals secured for Phase 2 IRX-211 and Phase 1 IRX-616a clinical trials
• Manufacturing of trial drugs underway; patient screening for IRX-211 expected in November
• Funding facility of $38.5 million secured to cover clinical development through Phase 2